These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8724556)

  • 21. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Wu KK; Shahar E; Davis CE
    Arterioscler Thromb; 1993 Dec; 13(12):1829-36. PubMed ID: 8241104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostatic risk factors of coronary artery disease in the Chinese.
    Ho CH; Wang SP; Jap TS
    Int J Cardiol; 1995 Aug; 51(1):79-84. PubMed ID: 8522401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation and regulation of platelet and fibrin hemostatic plug.
    Hawiger J
    Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic variability of hemostatic and fibrinolytic factors in young women.
    Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of blood pressure with fibrinolytic potential in the Framingham offspring population.
    Poli KA; Tofler GH; Larson MG; Evans JC; Sutherland PA; Lipinska I; Mittleman MA; Muller JE; D'Agostino RB; Wilson PW; Levy D
    Circulation; 2000 Jan; 101(3):264-9. PubMed ID: 10645922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
    Santamaría A; Borrell M; Oliver A; Ortín R; Forner R; Coll I; Mateo J; Souto JC; Fontcuberta J
    Am J Hematol; 2004 Aug; 76(4):348-52. PubMed ID: 15282667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
    Cushman M; Yanez D; Psaty BM; Fried LP; Heiss G; Lee M; Polak JF; Savage PJ; Tracy RP
    Am J Epidemiol; 1996 Apr; 143(7):665-76. PubMed ID: 8651228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen: its emerging role as a cardiovascular risk factor.
    Ernst E
    Angiology; 1994 Feb; 45(2):87-93. PubMed ID: 8129195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostasis and cardiovascular risk. The British and European experience.
    Miller GJ
    Arch Pathol Lab Med; 1992 Dec; 116(12):1318-21. PubMed ID: 1456878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of hemostatic markers in the pathogenesis of coronary diseases].
    Russo C
    Recenti Prog Med; 2002 Feb; 93(2):75-7. PubMed ID: 11887348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Münster study.
    Junker R; Heinrich J; Schulte H; Erren M; Assmann G
    J Hypertens; 1998 Jul; 16(7):917-23. PubMed ID: 9794731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated leukocytes and the hemostatic system.
    Lüscher EF
    Rev Infect Dis; 1987; 9 Suppl 5():S546-52. PubMed ID: 3317750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
    Folsom AR; Wu KK; Davis CE; Conlan MG; Sorlie PD; Szklo M
    Atherosclerosis; 1991 Dec; 91(3):191-205. PubMed ID: 1789804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemostatic anomalies and coronary risk].
    de Lorgeril M; Renaud S
    Rev Prat; 1992 Nov; 42(17):2136-40. PubMed ID: 1290035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
    Lippi G; Franchini M; Favaloro EJ; Targher G
    Semin Thromb Hemost; 2010 Feb; 36(1):59-70. PubMed ID: 20391297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo antithrombotic effect of wine consumption on human blood platelets and hemostatic factors.
    Mansvelt EP; van Velden DP; Fourie E; Rossouw M; van Rensburg SJ; Smuts CM
    Ann N Y Acad Sci; 2002 May; 957():329-32. PubMed ID: 12074991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related changes in the hemostatic system.
    Abbate R; Prisco D; Rostagno C; Boddi M; Gensini GF
    Int J Clin Lab Res; 1993; 23(1):1-3. PubMed ID: 8477086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.